Related Experiment Video
Updated: May 16, 2026

Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes
Published on: July 18, 2008
C. elegans as a genetic model system to identify Parkinson's disease-associated therapeutic targets
Julia Vistbakka1, Natalia VanDuyn, Garry Wong
1Department of Neurobiology, AI Virtanen Institute, University of Eastern Finland, Yliopistoranta 1, Kuopio 70210, Finland.
Abstract:
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms and the selective loss of dopaminergic neurons. The etiology of idiopathic PD is likely a combination of genetic and environmental factors. Despite findings from mammalian studies that have provided significant insight into the disorder, the molecular mechanisms underlying its pathophysiology are still poorly understood. The nematode Caenorhabditis elegans (C. elegans) is a powerful system for genetic analysis. Considering C. elegans short lifespan, fully sequenced genome, high genetic and neurobiochemical conservation with humans, as well as the availability of facile genetic tools, the nematode represents a highly efficient and effective model system to explore the molecular basis of PD. In this review we describe the utility of C. elegans for PD research, and the opportunity the model system presents to identify therapeutic targets.
More Related Videos
06:17Quantifying Levels of Dopaminergic Neuron Morphological Alteration and Degeneration in Caenorhabditis elegans
Published on: November 20, 2021
05:17Assessing Gastrointestinal Motility in Caenorhabditis elegans RAC1/CED-10 Mutants as a Tool to Study Early Parkinson's Disease
Published on: November 28, 2025
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction